BREVEGLIERI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 5.969
EU - Europa 2.711
AS - Asia 1.293
SA - Sud America 17
AF - Africa 11
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.012
Nazione #
US - Stati Uniti d'America 5.959
CN - Cina 950
PL - Polonia 815
IT - Italia 581
UA - Ucraina 404
DE - Germania 307
TR - Turchia 234
GB - Regno Unito 183
SE - Svezia 164
FI - Finlandia 101
FR - Francia 78
BE - Belgio 25
IN - India 19
VN - Vietnam 19
IR - Iran 16
BR - Brasile 12
RU - Federazione Russa 11
KR - Corea 10
NL - Olanda 10
AU - Australia 9
ID - Indonesia 9
RO - Romania 9
HK - Hong Kong 8
CA - Canada 7
MY - Malesia 7
CH - Svizzera 5
TN - Tunisia 5
TW - Taiwan 5
EG - Egitto 4
ES - Italia 4
JP - Giappone 4
SG - Singapore 4
AR - Argentina 3
GR - Grecia 3
CZ - Repubblica Ceca 2
MX - Messico 2
PK - Pakistan 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BG - Bulgaria 1
CO - Colombia 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
IE - Irlanda 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MA - Marocco 1
MT - Malta 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
TH - Thailandia 1
Totale 10.012
Città #
Warsaw 808
Woodbridge 698
Fairfield 558
Chandler 557
Ann Arbor 492
Jacksonville 485
Houston 477
Ashburn 399
Beijing 340
Wilmington 274
Seattle 224
Ferrara 223
Nanjing 182
Cambridge 166
Izmir 145
Princeton 116
Bologna 87
Boardman 85
Addison 84
New York 75
Milan 66
Shanghai 61
Bremen 55
Shenyang 53
San Diego 50
Redwood City 48
Nanchang 46
Falls Church 36
Hebei 35
Dearborn 31
Changsha 27
Zhengzhou 25
Auburn Hills 24
Jiaxing 23
San Jose 23
Brussels 21
Mountain View 21
Tianjin 21
Dong Ket 19
Guangzhou 17
Norwalk 16
Jinan 15
Orange 14
Ferrara di Monte Baldo 13
Kunming 13
Ningbo 13
London 12
Hefei 10
Indiana 10
Napoli 10
Des Moines 9
Hangzhou 9
Leawood 9
Lanzhou 8
Los Angeles 8
Washington 8
Jakarta 7
Leiden 7
Fuzhou 6
Hong Kong 6
Kraków 6
San Mateo 6
Sydney 6
Taizhou 6
Cattolica 5
Lappeenranta 5
Pars 5
San Francisco 5
Taipei 5
Verona 5
Chengdu 4
Philadelphia 4
Pune 4
Ravenna 4
Rome 4
Singapore 4
Ardabil 3
Bournemouth 3
Buenos Aires 3
Changchun 3
Florence 3
Gent 3
Kilburn 3
Kota Bharu 3
Kundan 3
Redmond 3
Rotterdam 3
Shaoxing 3
Southwark 3
Taiyuan 3
Tappahannock 3
Waban 3
Wuhan 3
Albinea 2
Ankara 2
Augusta 2
Aversa 2
Bern 2
Campobasso 2
Cartura 2
Totale 7.523
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 298
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 276
A validated cellular biobank for β-thalassemia 262
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 220
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 203
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 190
A validated THALAMOSS cellular biobank for β-thalassemia 181
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 162
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 161
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 158
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 140
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 139
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 131
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 131
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 129
SPR-based non-invasive prenatal testing for fetal sex determination 128
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 123
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 118
null 117
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 115
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 113
null 107
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 106
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 105
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 105
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 104
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 104
null 103
null 102
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 101
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 100
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 100
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 99
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 98
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients. 96
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 96
null 96
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 95
null 94
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 92
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 92
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 91
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 89
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 88
null 88
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 87
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 86
Non-invasive Prenatal Testing Using Fetal DNA 86
null 85
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 85
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 82
Detection of genomic disorders in unamplified human genomic DNA using an ultrasensitive surface plasmon resonance imaging method 80
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 80
TNF-alpha induced release of IL-8 by IB3-1 cells encapsulated in alginate microbeads 79
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 79
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 78
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 78
Antisense PNA and PNA-peptide conjugates for the modulation of the beta-globin gene splicing 75
null 75
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 74
Gene therapy combined with HbF induction in beta-thalassemia 74
MTOR and STAT3 pathway hyper-activation is associated with elevated interleukin-6 levels in patients with shwachman-diamond syndrome: Further evidence of lymphoid lineage impairment 74
Development and molecular characterization of transgenic mice for beta-thalassemia 73
Alteration of microRNA biological activity with peptide nucleic acid 73
SPR-based identification of microRNAs 73
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 72
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 70
null 69
Surface Plasmon Resonance Imaging (SPR-I), peptide nucleic acid (PNA) probes and nanoparticle-enhancement for PCR-free ultrasensitive detection of beta-thalassemia mutations in human genomic DNA 69
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 68
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 68
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 68
Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of beta o 39 thalassemia mutation. 67
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 67
Targeting the miR-221/miR-222 cluster in cancer therapy 66
PNA-mediated alteration of mRNA splicing 65
Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus 64
Inhibition of micro RNA 221 biological activity with an anti-miR-221 peptide nucleic acid 64
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 64
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 63
Peptide nucleic acids targeting miR-221 in human breast cancer: uptake and modulation of miR-221 biological functions. 62
Gene therapy and fetal hemoglobin induction 62
null 61
Inhibition of micro RNA 210 biological activity with an anti-miR-210 peptide nucleic acid 60
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 60
Detection of disorders in unamplified human genomic DNA 59
Multiple levels of control of the expression of the human AβH-J-J locus encoding aspartyl-β-hydroxylase, junctin, and junctate 58
Cellular biosensors for the identification of fetal hemoglobin inducers 58
Peptide nucleic acids targeting miR-221 in human gliomas: uptake and modulation of miR-221 biological functions 58
Readthrough of the premature stop codon beta039-thalassemia 57
Generation and molecular characterization of a transgenic mouse line carrying a mutated human °39 thalassemia -globin gene 57
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 57
Production of a cellular model for the screening of inducers of fetal haemoglobin 56
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 54
Molecular regulation of the expression of AbetaHJ-J locus, encoding Aspartyl-beta-hydroxylase, Junctin and Junctate 54
Peptide nucleic acids targeting miR-221 in breast cancer cell lines: uptake and modulation of miR-221 and p27kip1 biological function 53
Set up of a NK cell-sensitive tumour model in C57BL/6 mice 52
Non-invasive prenatal detection of beta-thalassemia mutations in maternal plasma using Droplet Digital PCR 52
Polyarginine peptide nucleic acids inhibit biological activity if microRNA 210 48
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 48
Totale 9.552
Categoria #
all - tutte 33.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 701
Totale 33.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019793 0 0 0 0 0 0 0 0 0 212 190 391
2019/20201.927 347 59 62 223 114 205 155 178 165 254 113 52
2020/20211.832 128 98 113 122 148 204 118 156 66 223 302 154
2021/20221.223 139 103 33 40 85 70 60 48 51 110 104 380
2022/20231.278 137 124 25 161 224 167 74 116 130 10 52 58
2023/2024583 50 107 35 31 64 156 82 42 11 5 0 0
Totale 10.271